A Phase 1, Single-Center, Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution
Latest Information Update: 17 May 2021
At a glance
- Drugs SM 04755 (Primary)
- Indications Psoriasis; Tendinitis
- Focus Adverse reactions
- Sponsors Biosplice Therapeutics
Most Recent Events
- 20 Apr 2018 New trial record